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Background. There is an epidemic of kidney disease among
the Zuni Indians. In collaboration with health care providers
and research institutions, the Zuni Pueblo established the Zuni
Kidney Project to reduce the burden of kidney disease.
Methods. The Zuni Kidney Project conducted a population-
based, cross-sectional survey to estimate the prevalence of al-
buminuria, hematuria, and related risk factors. Neighborhood
household clusters served as the sampling frame. Participants
completed a questionnaire, donated blood and urine samples,
and had blood pressure, height, and weight measured. This sur-
vey provided the foundation for ongoing studies to identify ge-
netic and environmental risk factors for disease susceptibility
and progression.
Results. Age and gender distributions among survey partic-
ipants were similar to those in the eligible Zuni population.
Prevalence of incipient albuminuria (IA) (0.03≤ urine albu-
min:creatinine ratio, UACR <0.3) and overt albuminuria (OA)
(UACR <0.3) were higher among diabetics [IA 34.3% (28.3,
40.4%); OA 18.6% (13.7, 23.6%)] than nondiabetics [IA 11.1%
(9.3, 12.8%); OA 1.7% (1.0, 2.5%)]. Nondiabetics comprised
58.6% (52.2, 65.0%) and 30.9% (19.9, 41.9%) of participants
with IA and OA, respectively. The prevalence of hematuria
was higher among diabetics [≥ trace 47.0% (40.7, 53.4); ≥50
red blood cell/lL 25.8% (20.3, 31.4%)] than nondiabetics [≥
trace 31.1% (28.5, 33.7%); ≥50 red blood cell/lL 16.6% (14.5,
18.7%)]. Hypertension was associated with albuminuria among
diabetic and nondiabetic participants. Hypercholesterolemia
was associated with albuminuria among nondiabetic partici-
pants. Diabetes and alcohol use were associated with hematuria.
Conclusion. The high prevalences of albuminuria among
nondiabetics and of hematuria among diabetics and nondiabet-
ics are consistent with high rates of nondiabetic kidney disease
among Zuni Indians with and without diabetes.
Key words: albuminuria, proteinuria, hematuria, American Indians, di-
abetic and nondiabetic kidney disease, risk factors, obesity, hyperten-
sion, hypercholesterolemia, epidemiology.
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Resumen
Antecedentes. Existe una epidemia de enfermedad renal en la
etnia Zuni. En colaboracio´n con los proveedores de salud y con
centros de investigacio´n, el Pueblo Zuni establecio´ el Proyecto
Renal Zuni (PRZ), con el objetivo de disminuir la prevalencia
de la enfermedad renal.
Me´todos. El PRZ condujo un estudio transversal para es-
timar la prevalencia de albuminuria, hematuria y los factores
de riesgo asociados a enfermedad renal en esta poblacio´n. Los
participantes llenaron un cuestionario, aportaron muestras de
sangre y orina y registraron su peso, estatura y presio´n arterial.
La encuesta aporto´ las bases para estudios concurrentes encam-
inados a identificar factores de riesgo gene´ticos y ambientales
que influyen en la susceptibilidad y avance de la enfermedad
renal.
Resultados. La distribucio´n por edad y sexo en el grupo
de estudio fue similar a la de la poblacio´n Zuni elegible. La
prevalencia de albuminuria incipiente (AI) (0.03 ≤ razo´n albu-
mina:creatinina urinaria, RACR < 0.3) y albuminuria franca
(AF) (RACR ≥ 0.3) fueron ma´s altas en los diabe´ticos [AI:
34.3% (28.3, 40.4%); AF: 18.6% (13.7, 23.6%) que en los no
diabe´ticos [AI: 11.1% (9.3, 12.8%); AF: 1.7%, (1.0, 2.5%)].
Los no diabe´ticos representaron el 58.6% (52.2, 65.0%) y el
30.9% (19.9, 41.9%) de los participantes con AI y AF, respec-
tivamente. La prevalencia de hematuria fue ma´s alta entre los
diabe´ticos [≥ trazas: 47.0% (40.7, 53.4%) ≥ 50 eritrocitos/lL:
25.8% (20.3, 31.4%)] que entre los no diabe´ticos [≥ trazas:
31.1% (28.5, 33.7%) ≥ 50 eritrocitos/lL: 16.6% (14.5, 18.7%)].
La hipertensio´n se asocio´ con albuminuria en ambos grupos.
Hipercolesterolemia se asocio´ con albuminuria entre los partic-
ipantes no diabe´ticos. Tanto diabetes como la ingesta de alcohol
se asociaron con hematuria.
Conclusion. Tanto la elevada prevalencia de albuminuria en-
tre los no diabe´ticos, como la de hematuria entre diabe´ticos y no
diabe´ticos, son consistentes con las altas tasas de enfermedad
renal no diabe´tica observadas entre la poblacio´n diabe´tica y no
diabe´tica de la etnia Zuni.
Similar to other disadvantaged minorities, American
Indians have a disproportionate burden of kidney
disease [1]. The prevalence of albuminuria among
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American Indians is higher than in the U.S. population
[2–4]. In the Strong Heart Study, the prevalence of albu-
minuria among American Indians aged 45 to 74 years in
Arizona (49.8%), Oklahoma (21.3%), and the Dakotas
(19.3%) was higher than that in the general U.S. pop-
ulation (11.1%). The age- and gender-adjusted preva-
lence of end-stage renal disease among American Indi-
ans [3552 per million population (pmp)] approaches that
among African Americans (4368 pmp) [1] and is 3.7-fold
higher than that among European Americans (970 pmp)
[1]. Among individuals with albuminuria, the risk for car-
diovascular disease exceeds that for end-stage renal dis-
ease. Thus, there is an urgent need for community-based
screening and the development of primary and secondary
prevention programs.
This paper describes how the Zuni Pueblo, located in an
isolated rural portion of New Mexico (NM), responded to
an epidemic of kidney disease. The Pueblo formed broad-
based collaborations with health care providers (Indian
Health Service, Dialysis Clinic, Inc.) and research insti-
tutions [University of New Mexico (UNM), Southwest
Foundation for Biomedical Research] to establish the
Zuni Kidney Project (ZKP) and reduce the burden of
kidney disease.
In 2000, the age- and gender-adjusted prevalence of
end-stage renal disease (ESRD) in Zuni [17,400 per mil-
lion population (pmp)] was 18.5- and 4.1-fold higher than
that among European Americans and African Ameri-
cans, respectively, and 5.3-fold higher than the composite
American Indian rate [1, 5]. Previous studies indicated
that high rates of diabetic and nondiabetic kidney dis-
ease may contribute to this epidemic [6, 7]. However,
these studies were not population-based and may have
contained significant selection bias.
The ZKP recognized the need to precisely estimate
the prevalence of kidney disease and related risk factors.
Thus, it conducted a population-based cross-sectional
survey of the Zuni Pueblo [5]. The ZKP is presently
conducting additional studies to identify genetic and en-
vironmental risk factors for the development and pro-
gression of kidney disease and cardiovascular diseases.
Specifically, the ZKP is collaborating with UNM’s Cen-
ter for Environmental Health (funded by the National
Institute of Environmental Health Sciences) to iden-
tify environmental and vocational factors associated with
kidney disease. It is also participating in a National
Institutes of Health-funded consortium, Family Inves-
tigation of Nephropathy and Diabetes, charged with
identifying genes that increase susceptibility to diabetic
nephropathy and retinopathy [8]. The ZKP also is con-
ducting a National Institutes of Health-funded study of
extended families to identify susceptibility genes for di-
abetic and nondiabetic kidney disease and intermediate
phenotypes.
STUDY POPULATION AND METHODS
Approximately 80% of all Zuni Indians live in the Zuni
Pueblo, located in McKinley County, NM [9]. There are
more than 2000 households and 10,000 tribal members in
the pueblo [9]. The median age is 26 years, and only 8%
of the population is aged ≥60 years [9]. Ninety percent
of the residents speak the Zuni language (Shiwi) [10].
The majority (59%) of adults have graduated from high
school [10]. Major occupations include jewelry making,
farming, sheepherding, and government jobs.
Community involvement is essential to the success
of the ZKP. Tribal members, fluent in both Shiwi and
English, were trained as recruiters. The study coordina-
tor (A. B.) was a well-respected Zuni educator. Tribal
leaders and community elders had continuing input into
study goals and design. Focus groups were held to de-
fine specific aims, identify the most efficient methodology,
and develop research instruments. A community-wide
education program, including age-appropriate education
materials, school meetings, childcare centers, community
health fairs, radio programs, and newspaper articles, was
developed to maximize participation.
The survey was conducted from February 1999 to April
2002 [5]. All Zuni Indians ≥5 years of age (N = 9228)
[9] were eligible to participate. We used a household
sampling frame within neighborhood clusters to max-
imize participation and reduce differential-surveillance
bias. The UNM Human Research Review Committee,
the Indian Health Service Institutional Review Board,
and the Zuni Tribal Council approved the study. A ques-
tionnaire with sections on demographics, medical history,
social history, risk factors, and family structure was ad-
ministered [5]. The reliability and validity of the instru-
ment have been demonstrated [5]. Participants donated
blood and urine samples and had blood pressure (BP),
height, and weight measured. Serum glucose, total choles-
terol, glycosylated hemoglobin (HbA1c), and urine cre-
atinine were measured [5]. Urine albumin was assayed
in spot-urine specimens by rate nephelometry, and ex-
pressed as urine albumin to creatinine ratio (UACR)
[11].
Albumin excretion was classified as normal (UACR
<0.03), incipient (IA) (0.03≤UACR <0.3), or overt (OA)
(UACR ≥0.3) [11]. Participants were classified as dia-
betic if they had a prior history of diabetes, random
glucose ≥200 mg/dL, or HbA1c >7.0% [11]. Participants
with HbA1c between 6.0% and 7.0%, a random glucose
<200 mg/dL, and no prior history of diabetes were clas-
sified as having an “indeterminate” diabetes status. As-
sessing the prevalence of albuminuria and hematuria in
both the diabetic and indeterminate groups enabled us to
obtain conservative prevalence estimates among partici-
pants with a low probability of diabetes [12]. Participants
aged ≥20 years were classified as overweight if their body
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Table 1. Prevalencea (%) of incipient and overt albuminuria, hematuria ≥ trace and ≥50 RBC/lL, overweight, obesity, hypertension, and
hypercholesterolemia, stratified by sex and diabetes status, among ZKP participants
Participants without diabetes (N = 1202) Participants with diabetes (N = 236)
F (N = 578) M (N = 624) F (N = 162) M (N = 74)
Incipient albuminuria 9.2f (6.8, 11.5) 12.8b,f (10.2, 15.4) 32.7 (25.5, 39.9) 37.8 (26.8, 48.9)
Overt albuminuria 1.2f (0.3, 2.1) 2.2f (1.1, 3.4) 17.9 (12.0, 23.8) 20.3 (11.1, 29.4)
Hematuria ≥ trace 39.8 (35.8, 43.8) 23.1c,f (19.8, 26.4) 47.5 (39.8, 55.2) 45.9 (34.6, 57.3)
Hematuria ≥50 RBC/lL 24.9 (21.4, 28.4) 9.0c,g (6.7, 11.2) 27.2 (20.3, 34.0) 23.0 (13.4, 32.6)
Overweight 34.1 (30.2, 38.0) 26.4d,g (22.9, 29.9) 40.6 (33.0, 48.2) 45.2 (33.8, 56.6)
Obesity 30.6g (26.8, 34.4) 19.6c (16.5, 22.8) 45.0 (37.3, 52.7) 27.4d (17.2, 37.6)
Hypertension 18.7f (15.5, 21.9) 31.1c,f (27.5, 34.8) 49.4 (41.5, 57.2) 71.4c (60.8, 82.0)
Hypercholesterolemia 27.4f (21.2, 28.3) 36.9c (33.1, 40.6) 39.5 (32.0, 47.0) 40.5 (29.4, 51.7)
Abbreviations are: ZKP, Zuni Kidney Project; F, females; M, males; RBC, red blood cell; incipient albuminuria, urine albumin:creatinine ratio ≥0.03 and <0.3; overt
albuminuria = urine albumin:creatinine ratio ≥0.3; overweight, body mass index ≥85th and <95th percentile if aged <20 years, body mass index ≥25 and <30 if aged
≥20 years; obesity, body mass index ≥95th percentile if aged <20 years, body mass index ≥30 if aged ≥20 years; hypertension, prior history of hypertension or systolic
or diastolic blood pressure ≥95th percentile if aged <18 years, prior history of hypertension or systolic or diastolic blood pressure ≥140 or ≥90 mm Hg, respectively, if
aged ≥18 years; hypercholesterolemia, total serum cholesterol ≥170 mg/dL if aged <20 years, total serum cholesterol ≥200 mg/dL if aged ≥20 years. 95% CI is reported
in parentheses.
aVariance estimates are adjusted for dependencies created by sampling within families.
bP<0.05; cP<0.001; dP<0.01 for comparison between females and males.
eP<0.05; fP<0.001; gP<0.01 for comparison between diabetes status, within gender.
mass index (BMI) was ≥25 and <30, and obese if BMI
≥30 [11]. Participants aged 5 to 19 years were classified
as overweight if their BMI was between the 85th and
94th percentiles, and obese if BMI was at or above the
95th percentile [11]. Participants aged ≥18 years were
classified as hypertensive if they had a prior history of
hypertension, or had systolic or diastolic BP ≥140 or
≥90 mm Hg, respectively [11]. Participants <18 years of
age were classified as hypertensive if they had a prior his-
tory or had systolic or diastolic BP ≥95th percentile for
age and height [11]. Among participants aged <20 years
and ≥20 years, hypercholesterolemia was defined as to-
tal cholesterol ≥170 or ≥200 mg/dL, respectively [11].
Alcohol use was defined as a self-report of any alcohol
consumption for a duration >10 years.
Statistical analysis
Prevalence of albuminuria and hematuria, and risk fac-
tors were expressed as percentages with 95% confidence
intervals. Estimates of the variances and covariances were
obtained using Taylor series linearization. We used mul-
tivariate generalized estimating equations to test for as-
sociations of putative risk factors with albuminuria and
hematuria among participants aged ≥20 years. Separate
models were constructed for diabetic and nondiabetic
participants. All models included adjustments for age and
gender and controlled for dependencies created by the
sampling design. The level of statistical significance was
P<0.05.
RESULTS
Study sample
Women comprised 51.7% (95% CI 49.2, 54.2) of study
participants (N = 1510) and 51.9% of the eligible Zuni
Tribal Population (ZTP). The proportion of people aged
≥40 years was similar among participants [28.3% (26.1,
30.6)] and the ZTP (29.5%). Among those aged ≥25
years, high school graduates comprised 62.3% (59.1, 65.5)
of participants versus 58.7% of the ZTP. Although the
study sample appeared to be representative of the ZTP,
unidentified sources of bias cannot be excluded.
Diabetes
Among participants aged ≥5 years, the prevalence of
diabetes was 15.6% (13.8, 17.5). The prevalence of dia-
betes was higher among women [20.7% (17.9, 23.6)] than
men [10.2% (8.0, 12.3)] (P<0.001). Only 4.8% (3.7, 5.8)
of participants had an indeterminate diabetes status.
Albuminuria
Prevalence estimates of IA and OA were higher
among diabetic than nondiabetic participants (P<0.001)
(Table 1). The proportion of nondiabetic participants
among those with IA and OA were 58.6% (52.2, 65.0) and
30.9% (19.9, 41.9), respectively. Among all participants
with UACR ≥0.03, 52.2% (46.5, 57.9) were nondiabetics,
42.4% (36.7, 48.0) were diabetics, and 5.4% (2.8, 8.0) had
an indeterminate diabetes status.
Hematuria
The prevalence estimates of hematuria ≥ trace and
≥50 red blood cell/lL were both higher among diabetic
than nondiabetic participants (P<0.01 and P<0.001, re-
spectively) (Table 1). Among nondiabetic participants,
the prevalence of hematuria was higher among women
than men (P<0.001). The prevalence of hematuria was
similar among male and female diabetic participants.
Among participants with hematuria ≥ trace, 21.7% (18.1,
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Table 2. Odds ratios for IA and OA and hematuria ≥ trace, adjusted for age and gender, among survey participants aged ≥20 years, stratified by
diabetes status (multivariate model)
Participants with diabetes (N = 203) Participants without diabetes (N = 714)
IA and OA Hematuria IA and OA Hematuria
Risk factor IA OA combined ≥ trace IA OA combined ≥ trace
Overweight 0.7 0.5 0.7 1.0 1.9a 0.7 1.6 0.7
(0.3, 1.6) (0.1, 1.8) (0.3, 1.6) (0.4, 2.5) (1.1, 3.4) (0.2, 2.4) (0.9, 2.7) (0.5, 1.1)
Obesity 0.7 0.9 0.8 1.2 1.8 1.1 1.6 1.4
(0.3, 1.7) (0.2, 3.3) (0.3, 2.0) (0.4, 3.1) (0.9, 3.3) (0.3, 4.2) (0.9, 2.8) (0.9, 2.0)
0.9 4.2b 1.3 1.6 3.9c 2.0 3.5c 0.9
Hypertension (0.5, 1.6) (1.4, 12.4) (0.7, 2.4) (0.8, 2.9) (2.4, 6.3) (0.7, 5.6) (2.3, 5.5) (0.6, 1.3)
Hypercholesterolemia 1.7 2.1 1.8 0.7 2.2c 2.7a 2.3c 1.0
(0.9, 3.3) (0.9, 5.2) (0.9, 3.3) (0.4, 1.3) (1.4, 3.5) (1.0, 7.2) (1.5, 3.6) (0.7, 1.5)
Alcohol use (>10 years) 2.2a 1.7 2.2a 2.4a 1.7a 2.7 1.8a 1.3
(1.0, 4.8) (0.6, 4.8) (1.1, 4.4) (1.2, 4.7) (1.0, 2.9) (0.9, 8.3) (1.1, 3.0) (0.9, 2.0)
Abbreviations are: IA, incipient albuminuria; OA, overt albuminuria; incipient albuminuria, urine albumin:creatinine ratio ≥0.03 and <0.3; overt albuminuria, urine
albumin:creatinine ratio ≥0.3; overweight, body mass index ≥25 and <30, obesity, body mass index ≥30; hypertension, prior history of hypertension or systolic or
diastolic blood pressure ≥140 or ≥90 mm Hg, respectively; hypercholesterolemia, total serum cholesterol ≥200 mg/dL. 95% CI is reported in parentheses.
aP<0.05; bP<0.01; cP<0.001.
25.3) were diabetic, 73.2% (69.3, 77.0) were nondiabetic,
and 5.1% (3.2, 7.0) had an indeterminate diabetes sta-
tus. Among those with hematuria ≥50 red blood cell/lL,
22.4% (17.5, 27.4) were diabetic, 73.5% (68.3, 73.8) were
nondiabetic, and 4.0% (1.7, 6.4) had an indeterminate
diabetes status.
Overweight, obesity, hypertension, and
hypercholesterolemia
Diabetic participants were more likely to be over-
weight than were nondiabetic participants (P < 0.01)
(Table 1). Among nondiabetic participants, being over-
weight was more common among women than men
(P < 0.01). The prevalence of obesity was higher among
diabetic than nondiabetic participants (P < 0.01). Among
both diabetic and nondiabetic participants, women were
more likely to be obese than men (P < 0.01). Hyperten-
sion was more common among diabetic than nondiabetic
participants (P < 0.001) and among men than women
(P < 0.001). Among nondiabetic participants, hyper-
cholesterolemia was more common among men than
women (P < 0.001).
Risk factors for albuminuria and hematuria
Diabetes was associated with albuminuria and hema-
turia (Table 2). Hypertension was associated with
albuminuria among both diabetic and nondiabetic par-
ticipants. Hypercholesterolemia was associated with
albuminuria among nondiabetic but not diabetic partic-
ipants. Alcohol use (>10 years) was associated with al-
buminuria among diabetic and nondiabetic participants
and with hematuria among nondiabetic participants.
DISCUSSION
The Zuni Pueblo, recognizing the threat to the commu-
nity posed by the epidemic kidney disease, established the
ZKP. Broad-based community support enabled the ZKP
to recruit a representative sample of the Zuni Pueblo.
The survey provided evidence that diabetes, hyperten-
sion, and alcohol were significant risk factors for albumin-
uria, and that alcohol use was a risk factor for hematuria
among nondiabetic participants.
The prevalence of albuminuria among nondiabetic
participants was one of the highest reported among non-
diabetic American Indians [13]. The prevalence of hema-
turia was higher than that observed among the Navajo
Indians [14]. The high rates of albuminuria among non-
diabetic participants and of hematuria among both dia-
betic and nondiabetic participants support the hypoth-
esis that nondiabetic kidney disease is common among
both diabetic and nondiabetic Zuni Indians. Mesana-
giopathic glomerulonephritis, frequently with glomeru-
lar deposition of immunoglobulin A, focal sclerosing
glomerulonephritis, membranous glomerulopathy, and
amyloidosis have been observed on kidney biopsies ob-
tained from Zuni Indians [15, 16].
The causes of the high rates of kidney disease are not
readily apparent. The prevalence of diabetes among the
Zuni Indians is higher than that in the United States popu-
lation and the composite American Indian rate [17]. Zuni
Indians with diabetes may be at higher risk for diabetic
and nondiabetic kidney disease compared with other di-
abetic American Indians. The observed associations of
hypertension with albuminuria are in concert with a
report by Hoehner et al [13]. The association of hy-
percholesterolemia with albuminuria among nondiabetic
patients is in concert with epidemiologic [18] and experi-
mental [19] studies, suggesting that hypercholesterolemia
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may be a risk factor for susceptibility to and progression
of kidney disease. However, the cross-sectional design of
our study precluded us from determining if hypercholes-
terolemia preceded the onset of kidney disease. Similar
to the results of previous studies in American Indians [3,
20], we did not demonstrate an independent association
between obesity and kidney disease. Among some non-
diabetic participants, albuminuria may be attributable to
the metabolic syndrome (syndrome X) [21]. An associ-
ation of albuminuria with the metabolic syndrome has
been observed in an Australian Aboriginal community
[22].
It is unlikely that traditional risk factors entirely ac-
count for the excess burden of kidney disease among
the Zuni Indians. Thus, the ZKP is exploring the role
of genetic and environmental factors. Among the Zuni
Indians, there is familial aggregation of diabetic and non-
diabetic kidney disease [15]. An apparent autosomal-
dominant mode of inheritance has been reported for im-
munoglobulin A nephropathy in a Zuni pedigree [23].
The ZKP is currently conducting studies to identify sus-
ceptibility genes for diabetic and nondiabetic kidney dis-
ease and intermediate phenotypes.
The present study has several unique strengths: (1) it
was population-based and used a sensitive method for
the measurement of albuminuria; (2) it obtained precise
estimates of putative risk factors for albuminuria; and (3)
it tested for associations of these risk factors with albu-
minuria and hematuria among diabetic and nondiabetic
participants. The study design enhanced economy and re-
cruitment but imposed significant limitations: (1) the use
of a single UACR determination may have led to the mis-
classification of some participants; (2) the measurement
of UACR, irrespective of medications, including those
known to significantly reduce proteinuria, may have led
to underestimation of the prevalence of albuminuria; and
(3) absence of formal glucose tolerance testing prevented
detection of individuals with impaired glucose tolerance
and albuminuria [3, 24].
The ZKP increased awareness of kidney disease in
the community through educational programs delivered
with the support of tribal leaders and local health care
providers. The ZKP provided an ongoing opportunity to
train tribal members in research methodology, with the
goal of empowering the community to conduct indepen-
dent health outcomes research. The ZKP has created the
infrastructure for future renal research to assess the role
of genetic, environmental, and genetic-environmental in-
teractions in the onset and progression of kidney disease
among the Zuni Indians.
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